Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Liam Condon acquired 30 shares of Johnson Matthey stock in a transaction dated Wednesday, January 22nd. The shares were bought at an average cost of GBX 1,362 ($17.00) per share, with a total value of £408.60 ($510.05).
Johnson Matthey Trading Up 0.7 %
Shares of JMAT stock opened at GBX 1,376 ($17.18) on Friday. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 63.15. The firm has a market cap of £2.40 billion, a P/E ratio of 2,372.41, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a 50 day moving average of GBX 1,378.95 and a 200-day moving average of GBX 1,508.96. Johnson Matthey PLC has a 12-month low of GBX 1,295.54 ($16.17) and a 12-month high of GBX 1,917.07 ($23.93).
Johnson Matthey (LON:JMAT – Get Free Report) last announced its quarterly earnings data on Wednesday, November 27th. The company reported GBX 57.40 ($0.72) earnings per share for the quarter. Johnson Matthey had a return on equity of 4.39% and a net margin of 0.84%. Sell-side analysts anticipate that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Cuts Dividend
Wall Street Analysts Forecast Growth
A number of analysts recently commented on the company. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,800 ($22.47) target price on shares of Johnson Matthey in a research report on Tuesday, December 17th. Berenberg Bank lowered their target price on Johnson Matthey from GBX 1,650 ($20.60) to GBX 1,500 ($18.72) and set a “hold” rating on the stock in a research report on Thursday, November 28th.
View Our Latest Analysis on JMAT
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Read More
- Five stocks we like better than Johnson Matthey
- Comparing and Trading High PE Ratio Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Where Do I Find 52-Week Highs and Lows?
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.